1. NOD-Like Receptors in Lung Diseases
2. aGlick, G.; Ghosh, S.; Roush, W. R.; Olhava, E. J. NLRP3 Modulators. US Patent US10,556,903B2, 2020.
3. bGlick, G.; Ghosh, S.; Roush, W. R.; Olhava, E. J.; O’Malley, D. Substituted Imidazo-quinolines as NLRP3 Modulators. US Patent WO2018152396A1, 2018.
4. cGlick, G.; Ghosh, S.; Roush, W. R.; Olhava, E. J.; O’Malley, D. NLRP3 Modulators. US Patent U10,533,005B2, 2020.
5. dDelMonte, A. J.; Geng, P.; Green, R. A.; Haley, M. W.; Glace, A. W.; Inankur, B.; Lou, S.; Ortiz, A.; Jamison, C. R.; Joe, C. L.; Kolotuchin, S.; Lin, D.; Rosso, V. W.; Shah, M.; Simmons, E. M.; Strotman, N. A.; Tan, Y. Substituted 4-Amino-1H-Imidazo[4,5-C]Quinoline Compounds and Improved Methods for their Preparation. US Patent WO2020037094A1, 2020.